Nova Patents
PL3773713T3

A leptin receptor agonist antibody for use in increasing bone mass in a subject suffering from metabolic dysfunction or hypoleptinemia

Abstract

This record has no abstract on file.

Term

12.5 yearsto projected expiry

Projected expiry 5 April 2039, counted from filing; an application has no term until it is granted.

  1. Priority and filed
  2. Published
  3. Today
  4. Projected expiry

36 members in 21 offices

This recordMember, by publication date11 more offices are in the list below

Members36

Family members, oldest first
DocumentOfficeKind
CA3094400A1CanadaA1
US2019309079A1United States of AmericaA1
WO2019195796A1World Intellectual Property Organization (WIPO)A1
AU2019249273A1AustraliaA1
MX2020010547AMexicoA
IL277634AIsraelA
IL277634D0IsraelD0
CN112040980AChinaA
KR20200141461ARepublic of KoreaA
EP3773713A1European Patent Office (EPO)A1
JP2021532057AJapanA
RU2020133603ARussian FederationA
US2022280641A1United States of AmericaA1
US11608381B2United States of AmericaB2
JP7420730B2JapanB2
JP2024045204AJapanA
EP3773713B1European Patent Office (EPO)B1
PT3773713TPortugalT
US12371503B2United States of AmericaB2
MX2025007820AMexicoA
EP4596043A2European Patent Office (EPO)A2
FI3773713T3FinlandT3
DK3773713T3DenmarkT3
JP7728374B2JapanB2
LT3773713TLithuaniaT
SI3773713T1SloveniaT1
PL3773713T3This recordPolandT3
SMT202500283T1San MarinoT1
KR102865078B1Republic of KoreaB1
RS67121B1SerbiaB1
EP4596043A3European Patent Office (EPO)A3
ES3037632T3SpainT3
US2025320301A1United States of AmericaA1
KR20250150148ARepublic of KoreaA
HRP20250986T1CroatiaT1
JP2025166129AJapanA